Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cd19 car-t cells (1 trial)
cd19-tricar-silk (2 trials)
cd19-tricar-t (3 trials)
cyclophosphamide (cytoxan) (1 trial)
fludarabine (fludara) (1 trial)
gpa-trimar-t (1 trial)
Leukemia (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 1)
Multiple Myeloma (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Trials (6 total)
Trial APIs (6 total)